WaveMan
WaveMan · Company
JBS · Jbs N.V.
> Search tickers & screens ⌘K
LIVE
← All companies

JBS JBS (JBS) Insider Trading, Ownership & Congress Trades

Food & Beverage · Meat packing plants · CIK 0001791942
Form 144 · 1
Insider buyers, 180 days
0
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
155
13F, latest reported quarter

What the filings say about JBS

Insiders, 180 days
-$2.5M net sold
1 seller · 0% of sales under a 10b5-1 plan
Planned sales (Form 144), 90 days
$2.5M
1 notice

JBS insider trades (Form 4)

Form 4 buys and sells (codes P and S). Grants, option exercises and conversions excluded.

Over the last 180 days, JBS N.V. insiders sold a net $2.5M of stock across 1 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-28.

Foreign private issuer: most of its insiders are exempt from SEC Form 4, but some still file it; those filings are listed below, and the record may be incomplete.

Insider
Filed
Shares
Value
Since filing
SELL
2026-08-25 SECtraded 2026-08-24
183,501
$2.5M
-9.9%
Context
  • First Form 4 purchase or sale (code P or S) here by this insider on our record.
  • No other insider sold within 30 days.
  • 155 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Global CFO and IRO Cavalcanti Guilherme Perboyre sold about $2.5M of JBS on Aug 24, 2026, the largest insider sale at the company on our record; 155 funds added in the latest 13F quarter.
1 transaction on record · a thin record, read with care
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Showing the latest few. to use the screener and CSV export. We store only your email; there is no password.
Seven facts, ranked against the sector · Rank is not a forecast
Insiders
net -$2.5M over 180 days
-$2.5M over 90 days
below 73% of Food & Beverage
Congress
no House purchase disclosed in the last 12 months
Funds
155 funds bought in last quarter
more than 50% of Food & Beverage
Revenue
no revenue reported in any filing
Margin
no margin: no revenue reported
Buybacks
no share repurchases reported
Short interest
12.9% of the float short (float per yahoo 2026-10-27) · 6.3 days to cover · settled 2026-10-15
What changed in the last 30 days
Nothing new filed in the last 30 days

Watch JBS

A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.

The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
+3.7%12M
-9%+8%+26%+43%2025-102025-122026-022026-042026-062026-082026-10 2026-08-24 · Cavalcanti Guilherme Perboyre sold $2.5M2026-08-21 · GUILHERME PERBOYRE CAVALCANTI filed to sell $2.5M
Insider sellForm 144 (planned sale)
Indexed to 100, dividend-adjusted, not a price chart. When a name files heavily, the largest trades are drawn first.

Who owns JBS: institutional holders (13F)

13F holdings, latest reported quarter
$2.4B
$592.7M
32,266,675 sh
$382.4M
$133.6M
8,004,059 sh
$95.3M

Congress trades in JBS

No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.

Activist and 5% holders (13D/13G)

No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.

JBS planned insider sales (Form 144)

Notice of intent to sell, filed before any sale
GUILHERME PERBOYRE CAVALCANTI
Filed 2026-08-21
$2.5M

JBS mutual fund holders (N-PORT)

Funds ranked by the share of their own portfolio in this stock (N-PORT).
Davis International Fund
$16.9M position · as of 2026-07-31
6.2%
Davis Select International ETF
$17.2M position · as of 2026-07-31
5.9%
Davis Select Worldwide ETF
$27.6M position · as of 2026-07-31
4.5%
Davis Global Fund
$41.8M position · as of 2026-07-31
4.5%
Davis New York Venture Fund
$269.7M position · as of 2026-07-31
3.5%
Selected American Shares
$60.4M position · as of 2026-06-30
2.9%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M · % is the share of the fund's own portfolio
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $2.5M sold by insiders over 180 days, 155 funds added last quarter, $2.5M in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
Same sector, ranked by filing activity
Sector by SEC SIC code

JBS financials

Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
2025-122024-122023-12
Gross profit$11.3B$11.6B$8.0B
Net income$2.2B$2.0B-$131.7M
SEC XBRL, fiscal years, as known on 2026-10-28

JBS Stock Sonar score 3/7 axes

Find similar shapesCompare

JBS ranks highest on institutional and government (50th percentile) and risk and compliance (18th), and lowest on insider conviction (13th), among Food & Beverage peers.

Insider conviction
13
Inputs
  • Net Form 4 buying (codes P and S), 180d-$2.5M · 25 pct, sector of 56
  • Insider buyers, 180d0 · 0 pct, sector of 56
Institutional and government
50
Inputs
  • Funds adding, latest quarter155 · 50 pct, sector of 79
  • Congress net buyers, 365dno Congress trades in 365 days
  • Federal contracts, 180dno federal contracts in 180 days
  • Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
18
Inputs
  • Short interest, % of float+12.9% · 18 pct, sector of 98
  • Recalls per $1B revenue, 3yrevenue under $50M or not filed, so a count cannot be scaled to size
  • EPA cases per $1B revenue, 5yrevenue under $50M or not filed, so a count cannot be scaled to size
  • New text in Risk Factors, latest 10-Kneeds two 10-Ks with a Risk Factors section (not 20-F filers or stubs)
4 not measured: Profitability, Financial health, Growth, US patents
  • Profitability needs 2 of 4 inputs, 0 present: fewer than four consecutive quarters of net income; fewer than four consecutive quarters of operating income
  • Financial health needs 1 of 2 inputs, 0 present: no debt line filed
  • Growth needs 1 of 2 inputs, 0 present: no backlog line filed, or no year-earlier backlog; no revenue for this year and the year before
  • US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet

3 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored

JBS filings, in plain words

Are JBS insiders buying or selling JBS?

In the 180 days to 2026-10-28, JBS insiders were net sellers, a net $2.5M across purchases and sales reported on Form 4, by 1 seller.

Are there planned insider sales of JBS?

Yes. 1 Form 144 notice of planned insider sales was filed in the 90 days to 2026-10-28, covering $2.5M of stock; the latest, by GUILHERME PERBOYRE CAVALCANTI, was filed 2026-08-21.

Read the full summary

In the 180 days to 2026-10-28, JBS insiders were net sellers of JBS, a net $2.5M across purchases and sales reported on Form 4 by 1 seller. Insiders filed 1 Form 144 notice of intent to sell in the 90 days to 2026-10-28, covering $2.5M of stock. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.

Explore insider trading and ownership data

Every company we track, ranked by each kind of filing